Whoa—This Guy Stayed Alive for 48 Hours Without Any Lungs

THE HUMAN BODY can only go without oxygen for 4 minutes before there’s irreversible brain damage. Death follows 4 to 6 ...

Surgeons keep man alive without lungs, paving new path to transplant

Missouri patient survives double-lung transplant after innovative 48-hour bridge therapy removes infected lungs, offering new ...
Scientific Research Publishing

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa ()

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...

Zenocutuzumab--zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...
McKnight's Long-Term Care News

Study: RSV infection linked to increased risk of heart attack, stroke among adults

Adults hospitalized with an acute respiratory syncytial virus (RSV) infection faced an increased risk of cardiorespiratory events such as heart attack or stroke in the weeks afterward, according to a ...

Intellia Therapeutics: 2 Major Catalysts Will Determine Stock's Trajectory In 2026

NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...

Aro Biotherapeutics Reports Preliminary Efficacy for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD)

Aro Biotherapeutics, a clinical-stage biotechnology company developing potent and tissue-targeted short-interfering RNA (siRNA) medicines, today announced interim data from a phase 1b study of ABX1100 ...

N.J. med spas are in crisis. Sudden law change leaves some fighting to survive.

It's not just Botox and IV therapy. The reversal of a COVID rule could upend family and maternal care, mental healthcare ...
CIDRAP

Study ties adult RSV hospitalization to a higher risk of heart and lung problems in next 6 months

This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...
Informationsdienst Wissenschaft

From theory to practice: €1.1 million for regulatory advice

Home > Pressemitteilung: From theory to practice: €1.1 million ... ForTra Prof. Dr. Martin Zörnig CEO ForTra gGmbH für Forschungstransfer der Else Kröner-Fresenius-Stiftung c/o EKFS Tel.: +49 6172 ...